1
|
Hu S, Liu X, Zhang S, Quan D. An Overview of Taste-Masking Technologies: Approaches, Application, and Assessment Methods. AAPS PharmSciTech 2023; 24:67. [PMID: 36788171 DOI: 10.1208/s12249-023-02520-z] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2022] [Accepted: 01/24/2023] [Indexed: 02/16/2023] Open
Abstract
It is well-known that plenty of active pharmaceutical ingredients (API) inherently possess an unpleasant taste, which influences the acceptance of patients, especially children. Therefore, manufacturing taste-masked dosage forms has attracted a lot of attention. This review describes in detail the taste-masking technologies based on the difference in the taste transmission mechanism which is currently available. In particular, the review highlights the application of various methods, with a special focus on how to screen the appropriate masking technology according to the properties of API. Subsequently, we overviewed how to assess taste-masking efficacy, guiding researchers to rationally design taste-masking formulations.
Collapse
Affiliation(s)
- Shuqin Hu
- Institute of Advanced Drug Delivery Technology, No.10 Xinghuo Avenue Jiangbei New Area, Nanjing, 210032, People's Republic of China.,China Pharmaceutical University, No. 639 Longmian Avenue, Nanjing, 211198, People's Republic of China
| | - Xiaoxuan Liu
- China Pharmaceutical University, No. 639 Longmian Avenue, Nanjing, 211198, People's Republic of China
| | - Shuangshuang Zhang
- Institute of Advanced Drug Delivery Technology, No.10 Xinghuo Avenue Jiangbei New Area, Nanjing, 210032, People's Republic of China
| | - Danyi Quan
- Institute of Advanced Drug Delivery Technology, No.10 Xinghuo Avenue Jiangbei New Area, Nanjing, 210032, People's Republic of China.
| |
Collapse
|
2
|
Kendall T, Stratford S, Patterson AR, Lunt RA, Cruickshank D, Bonnaud T, Scott CD. An industrial perspective on co-crystals: Screening, identification and development of the less utilised solid form in drug discovery and development. PROGRESS IN MEDICINAL CHEMISTRY 2021; 60:345-442. [PMID: 34147205 DOI: 10.1016/bs.pmch.2021.05.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
Active pharmaceutical ingredients are commonly marketed as a solid form due to ease of transport, storage and administration. In the design of a drug formulation, the selection of the solid form is incredibly important and is traditionally based on what polymorphs, hydrates or salts are available for that compound. Co-crystals, another potential solid form available, are currently not as readily considered as a viable solid form for the development process. Even though co-crystals are gaining an ever-increasing level of interest within the pharmaceutical community, their acceptance and application is still not as standard as other solid forms such as the ubiquitous pharmaceutical salt and stabilised amorphous formulations. Presented in this chapter is information that would allow for a co-crystal screen to be planned and conducted as well as scaled up using solution and mechanochemistry based methods commonly employed in both the literature and industry. Also presented are methods for identifying the formation of a co-crystal using a variety of analytical techniques as well as the importance of confirming the formation of co-crystals from a legal perspective and demonstrating the legal precedent by looking at co-crystalline products already on the market. The benefits of co-crystals have been well established, and presented in this chapter are a selection of examples which best exemplify their potential. The goal of this chapter is to increase the understanding of co-crystals and how they may be successfully exploited in early stage development.
Collapse
Affiliation(s)
- Thomas Kendall
- Technobis Crystallization Systems, Alkmaar, The Netherlands.
| | - Sam Stratford
- Johnson Matthey, Pharmorphix, Cambridge, United Kingdom
| | | | - Ruth A Lunt
- Johnson Matthey, Pharmorphix, Cambridge, United Kingdom
| | | | | | | |
Collapse
|
3
|
Recent Formulation Advances and Therapeutic Usefulness of Orally Disintegrating Tablets (ODTs). PHARMACY 2020; 8:pharmacy8040186. [PMID: 33050437 PMCID: PMC7712969 DOI: 10.3390/pharmacy8040186] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2020] [Revised: 09/25/2020] [Accepted: 10/09/2020] [Indexed: 01/02/2023] Open
Abstract
This review highlights the recent formulation advances (different methods of preparation involving various novel approaches) that have been advancing the use of ODT as a popular dosage form. Furthermore, the important characteristics of ODTs that are required for patient compliance and appropriate therapeutic benefit are discussed. In addition to conventional ODTs, ODTs formulated for controlled release of pharmaceuticals and taste masking are also discussed.
Collapse
|
4
|
Kumari N, Ghosh A. Cocrystallization: Cutting Edge Tool for Physicochemical Modulation of Active Pharmaceutical Ingredients. Curr Pharm Des 2020; 26:4858-4882. [PMID: 32691702 DOI: 10.2174/1381612826666200720114638] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2019] [Accepted: 05/16/2020] [Indexed: 02/08/2023]
Abstract
Cocrystallization is a widely accepted and clinically relevant technique that has prospered very well over the past decades to potentially modify the physicochemical properties of existing active pharmaceutic ingredients (APIs) without compromising their therapeutic benefits. Over time, it has become an integral part of the pre-formulation stage of drug development because of its ability to yield cocrystals with improved properties in a way that other traditional methods cannot easily achieve. Cocrystals are solid crystalline materials composed of two or more than two molecules which are non-covalently bonded in the same crystal lattice. Due to the continuous efforts of pharmaceutical scientists and crystal engineers, today cocrystals have emerged as a cutting edge tool to modulate poor physicochemical properties of APIs such as solubility, permeability, bioavailability, improving poor mechanical properties and taste masking. The success of cocrystals can be traced back by looking at the number of products that are getting regulatory approval. At present, many cocrystals have obtained regulatory approval and they successfully made into the market place followed by a fair number of cocrystals that are currently in the clinical phases. Considering all these facts about cocrystals, the formulation scientists have been inspired to undertake more relevant research to extract out maximum benefits. Here in this review cocrystallization technique will be discussed in detail with respect to its background, different synthesis approaches, synthesis mechanism, application and improvements in drug delivery systems and its regulatory perspective.
Collapse
Affiliation(s)
- Nimmy Kumari
- Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi - 835215, Jharkhand, India
| | - Animesh Ghosh
- Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi - 835215, Jharkhand, India
| |
Collapse
|
5
|
A novel bitter masking approach: Powder coating technology-take Sanhuang tablets as an example. J Drug Deliv Sci Technol 2019. [DOI: 10.1016/j.jddst.2019.04.028] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
6
|
Yoshida M, Kojima H, Uda A, Haraguchi T, Ozeki M, Kawasaki I, Yamamoto K, Yano I, Hirai M, Uchida T. Bitterness-Masking Effects of Different Beverages on Zopiclone and Eszopiclone Tablets. Chem Pharm Bull (Tokyo) 2019; 67:404-409. [DOI: 10.1248/cpb.c18-00502] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Affiliation(s)
- Miyako Yoshida
- School of Pharmaceutical Sciences, Mukogawa Women’s University
| | - Honami Kojima
- School of Pharmaceutical Sciences, Mukogawa Women’s University
| | - Atsushi Uda
- Department of Pharmacy, Kobe University Hospital
| | | | - Minoru Ozeki
- School of Pharmaceutical Sciences, Mukogawa Women’s University
| | - Ikuo Kawasaki
- School of Pharmaceutical Sciences, Mukogawa Women’s University
| | | | - Ikuko Yano
- Department of Pharmacy, Kobe University Hospital
| | - Midori Hirai
- Division of Pharmacokinetics, Kobe University Graduate School of Medicine
| | - Takahiro Uchida
- School of Pharmaceutical Sciences, Mukogawa Women’s University
| |
Collapse
|
7
|
Han X, Zhang DK, Zhang F, Lin JZ, Jiang H, Lan Y, Xiong X, Han L, Yang M, Fu CM. A Novel Strategy for Bitter Taste Masking of Gankeshuangqing Dispersible Tablets Based on Particle Coating Technology. Pharmacogn Mag 2017; 13:400-406. [PMID: 28839363 PMCID: PMC5551356 DOI: 10.4103/pm.pm_240_16] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2016] [Revised: 06/27/2016] [Indexed: 01/08/2023] Open
Abstract
BACKGROUND Currently, acute upper respiratory tract infections (AURTIs) are increasingly becoming a significant health burden. Gankeshuangqing dispersible tablets (GKSQDT) which have a good effect on treating AURTIs. GKSQDT is composed of baicalin and andrographolide. However, its severe bitterness limits application of patients. Due to the addition of plentiful accessories, common masking methods are unsuitable for GKSQDT. It is thus necessary to develop a new masking method. MATERIALS AND METHODS The Previous study showed that baicalin was less bitter than andrographolide. Thus, particle coating technology was adapted to prepare composite particles that baicalin coated on the surface of andrographolide to decrease bitterness. Initially, particle size of baicalin and coating time of composite was investigated to prepare composite. Then, scanning electron microscopy, wettability, and infrared (IR) spectrogram were used to characterize the microstructure of composite. Furthermore, electronic tongue test, animal preference experiment, and human sensory test were applied to evaluate the masking effect. RESULTS To produce composite, baicalin should be ground in vibromill for 6 min. Then, andrographolide fine powder was added to grind together for 6 min. Contact angle of composite was smaller than mixture, and more similar to baicalin. Other physical characterization including microstructure, wettability, and IR also suggested that andrographolide was successfully coated by baicalin superfine. Furthermore, taste-masking test indicated taste-masked tablets was less bitter than original tablets. CONCLUSION The study indicated that particle coating technology can be used for taste masking of GKSQDT without adding other substance. Moreover, it provides a new strategy of taste masking for national medicine. SUMMARY A new strategy to mask bitterness without adding any other substance based on coating technology was providedThe masking effect was confirmed by electronic tongue test, animal preference experiment and human sensory test. Abbreviations used: AURTIs: Acute Upper Respiratory Tract Infections; GSQDT: Gankeshuangqing Dispersible Tablets; IR: Infrared Spectrogram; LHPC: Low-substituted Hydroxypropyl Cellulose; CAs: Contact Angles; FTIR: Fourier Transform Infrared Spectra.
Collapse
Affiliation(s)
- Xue Han
- College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, PR China
| | - Ding-Kun Zhang
- College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, PR China
| | - Fang Zhang
- Pharmacy, Maternal and Child Health Care Hospital of Changzhi, Changzhi 046011, PR China
| | - Jun-Zhi Lin
- Central Laboratory, The Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Chengdu 610072, PR China
| | - Hong Jiang
- College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, PR China
| | - Yang Lan
- College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, PR China
| | - Xi Xiong
- College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, PR China
| | - Li Han
- College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, PR China
| | - Ming Yang
- Key Laboratory of Modern Preparation of Traditional Chinese Medicine, Ministry of Education, Jiangxi University of Traditional Chinese Medicine, Nanchang 330004, PR China
| | - Chao-Mei Fu
- College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, PR China
| |
Collapse
|
8
|
Shiraishi S, Haraguchi T, Nakamura S, Kojima H, Kawasaki I, Yoshida M, Uchida T. Suppression in Bitterness Intensity of Bitter Basic Drug by Chlorogenic Acid. Chem Pharm Bull (Tokyo) 2017; 65:151-156. [DOI: 10.1248/cpb.c16-00670] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Affiliation(s)
| | | | - Saki Nakamura
- School of Pharmaceutical Sciences, Mukogawa Women’s University
| | - Honami Kojima
- School of Pharmaceutical Sciences, Mukogawa Women’s University
| | - Ikuo Kawasaki
- School of Pharmaceutical Sciences, Mukogawa Women’s University
| | - Miyako Yoshida
- School of Pharmaceutical Sciences, Mukogawa Women’s University
| | - Takahiro Uchida
- School of Pharmaceutical Sciences, Mukogawa Women’s University
| |
Collapse
|
9
|
Rajesh AM, Popat KM. In vivo and in vitro taste masking of ofloxacin and sustained release by forming interpenetrating polymer network beads. Pharm Dev Technol 2016; 22:26-34. [DOI: 10.3109/10837450.2015.1131719] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Affiliation(s)
- A. Michael Rajesh
- Academy of Scientific and Innovative Research and
- Reverse Osmosis Membrane Division, Central Salt and Marine Chemicals Research Institute, Council of Scientific & Industrial Research (CSIR), Bhavnagar, India
| | - Kiritkumar Mangaldas Popat
- Academy of Scientific and Innovative Research and
- Reverse Osmosis Membrane Division, Central Salt and Marine Chemicals Research Institute, Council of Scientific & Industrial Research (CSIR), Bhavnagar, India
| |
Collapse
|
10
|
Kharb V, Saharan VA, Kharb V, Jadhav H, Purohit S. Formulation and characterization of taste masked ondansetron–magnesium aluminum silicate adsorption systems. Drug Dev Ind Pharm 2016; 42:1291-9. [DOI: 10.3109/03639045.2015.1128439] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Affiliation(s)
- Vandana Kharb
- Faculty of Pharmaceutical Sciences, Jodhpur National Unviersity, Boranada, Jodhpur, Rajasthan, India
- Department of Pharmaceutics, Sachdeva College of Pharmacy, Gharuan, District Mohali, Punjab, India
| | - Vikas Anand Saharan
- Department of Pharmaceutical Sciences, Sardar Bhagwan Singh PG Institute of Biomedical Sciences & Research, Balawala, Deharadun, Uttarakhand, India
| | - Vivek Kharb
- Torrent Pharmaceuticals Ltd, Baddi, Himachal Pradesh, India
| | - Hemant Jadhav
- Birla Institute of Technology and Science (BITS), Pilani, Rajasthan, India
| | - Suresh Purohit
- Department of Pharmacy, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
| |
Collapse
|